Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
465 |
|
Actual shortage: | 54 (12%) | |
Anticipated shortage: | 27 (6%) | |
Avoided shortage: | 8 (2%) | |
Resolved: | 376 (81%) | |
Discontinuation Reports |
68 |
|
To be discontinued: | 7 (10%) | |
Discontinued: | 51 (75%) | |
Reversed: | 10 (15%) | |
Late reports |
51 (10%) |
|
Overdue reports |
12 (14%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
METFORMIN | 500MG | TABLET | Resolved | 2023-08-29 | 2023-09-19 | 203144 |
SOLIFENACIN | 5MG | TABLET | Resolved | 2023-09-26 | 2023-12-01 | 205212 |
GALANTAMINE ER | 16MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-10-23 | 2024-04-04 | 207850 |
GABAPENTIN | 100MG | CAPSULE | Resolved | 2023-10-23 | 2023-11-14 | 207859 |
PREGABALIN | 150MG | CAPSULE | Resolved | 2023-10-23 | 2023-12-01 | 207862 |
PREGABALIN | 25MG | CAPSULE | Resolved | 2023-10-23 | 2024-03-09 | 207865 |
VALACYCLOVIR | 1000MG | TABLET | Resolved | 2023-10-23 | 2023-12-01 | 207872 |
VALACYCLOVIR | 500MG | TABLET | Resolved | 2023-10-23 | 2023-12-01 | 207875 |
CANDESARTAN | 32MG | TABLET | Resolved | 2023-10-23 | 2024-03-11 | 207878 |
OLMESARTAN | 40MG | TABLET | Resolved | 2023-10-23 | 2024-02-12 | 207885 |
IRBESARTAN | 300MG | TABLET | Resolved | 2023-10-23 | 2024-02-29 | 207903 |
TRAZODONE | 50MG | TABLET | Resolved | 2023-10-23 | 2023-12-01 | 207906 |
LACOSAMIDE | 150MG | TABLET | Resolved | 2023-11-22 | 2024-01-30 | 211034 |
PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2023-11-22 | 2023-12-26 | 211037 |
DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-11-22 | 2024-01-30 | 211052 |
GABAPENTIN | 300MG | CAPSULE | Resolved | 2023-11-22 | 2024-03-08 | 211055 |
PERINDOPRIL ERBUMINE | 8MG | TABLET | Resolved | 2023-11-22 | 2023-12-01 | 211058 |
PREGABALIN | 300MG | CAPSULE | Resolved | 2023-11-22 | 2024-02-21 | 211065 |
PREGABALIN | 75MG | CAPSULE | Resolved | 2023-11-22 | 2023-12-26 | 211068 |
SERTRALINE | 100MG | CAPSULE | Resolved | 2023-11-22 | 2023-12-01 | 211071 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-12-16 | 2021-12-17 | 151293 |
BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |
SOLIFENACIN | 5MG | TABLET | Discontinued | 2023-09-26 | 2023-09-26 | 205215 |
DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |